Yusuf Yazici Selected Research

Oral Ulcer (Mouth Ulcer)

1/2022	Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
9/2021	Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
1/2020	Management of Behçet syndrome.
11/2019	Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
1/2017	Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
4/2015	Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusuf Yazici Research Topics

Disease

40	Rheumatoid Arthritis 01/2020 - 06/2002
14	Pain (Aches) 03/2022 - 02/2007
6	Oral Ulcer (Mouth Ulcer) 01/2022 - 04/2015
6	Neoplasms (Cancer) 01/2020 - 01/2007
4	Vasculitis (Vasculitides) 10/2022 - 01/2012
4	Osteoarthritis 03/2022 - 05/2006
4	Rheumatic Diseases (Rheumatism) 09/2019 - 08/2011
3	Knee Osteoarthritis 03/2022 - 10/2020
3	Nausea 09/2021 - 04/2015
3	Ankylosing Spondylitis 12/2018 - 01/2010
3	Psoriatic Arthritis 01/2018 - 01/2010
3	Fatigue 06/2014 - 02/2007
2	Headache (Headaches) 09/2021 - 11/2019
2	Inflammation (Inflammations) 01/2021 - 11/2009
2	Diarrhea 11/2019 - 04/2015
2	Chronic Disease (Chronic Diseases) 09/2015 - 11/2009
2	Arthritis (Polyarthritis) 01/2010 - 05/2006
2	Thrombosis (Thrombus) 07/2007 - 12/2003
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Tendinopathy (Tendonitis) 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Eye Diseases (Eye Disease) 01/2020
1	Disease Progression 01/2020
1	Intervertebral Disc Degeneration 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Ulcer 01/2017
1	Vomiting 04/2015
1	Relapsing Polychondritis 10/2013
1	Myocarditis (Carditis) 10/2013
1	Drug-Related Side Effects and Adverse Reactions 12/2012
1	Necrosis 12/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2012
1	Autoimmune Diseases (Autoimmune Disease) 12/2012
1	Fibromyalgia (Fibrositis) 07/2012
1	Infections 02/2012
1	Aneurysm (Aneurysms) 01/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2007
1	Opportunistic Infections (Opportunistic Infection) 01/2007

Drug/Important Bio-Agent (IBA)

13	Methotrexate (Mexate)FDA LinkGeneric 09/2015 - 08/2002
12	Biological ProductsIBA 01/2020 - 05/2006
5	apremilastIBA 01/2022 - 04/2015
5	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 05/2009
5	Antirheumatic Agents (DMARD)IBA 01/2017 - 01/2008
4	lorecivivintIBA 03/2022 - 01/2020
4	ametantrone (HAQ)IBA 09/2019 - 04/2008
4	Infliximab (Remicade)FDA Link 01/2018 - 10/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2017 - 01/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 05/2009
3	Adalimumab (Humira)FDA Link 01/2020 - 10/2013
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2011
3	Certolizumab Pegol FDA Link 09/2017 - 08/2011
3	CytokinesIBA 07/2015 - 05/2006
3	tocilizumab (atlizumab)FDA Link 05/2013 - 01/2007
3	Azathioprine (Imuran)FDA LinkGeneric 12/2012 - 01/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022 - 01/2018
2	Abatacept (Orencia)FDA Link 01/2020 - 02/2012
2	Rituximab (Mabthera)FDA Link 01/2018 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017 - 10/2003
2	GlucocorticoidsIBA 07/2015 - 01/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 01/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 01/2009
2	Monoclonal AntibodiesIBA 01/2010 - 01/2007
2	Anti-Citrullinated Protein AntibodiesIBA 08/2009 - 02/2007
2	antineoplaston A10 (A 10)IBA 08/2008 - 02/2007
1	salicylhydroxamic acid (SHAM)IBA 03/2022
1	ORALIT (ORS)IBA 06/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	Clk dual-specificity kinasesIBA 10/2020
1	Dyrk KinasesIBA 10/2020
1	CateninsIBA 01/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020
1	C-Reactive ProteinIBA 09/2019
1	secukinumabIBA 12/2018
1	tofacitinibIBA 08/2018
1	Janus Kinase InhibitorsIBA 08/2018
1	Biosimilar PharmaceuticalsIBA 01/2018
1	CT-P13IBA 01/2018
1	Pharmaceutical PreparationsIBA 12/2012
1	Colchicine FDA LinkGeneric 12/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2012
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	golimumab FDA Link 01/2010
1	CholesterolIBA 11/2009
1	AntibodiesIBA 08/2009
1	Rheumatoid FactorIBA 01/2009
1	amsonic acid (DAS)IBA 08/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007
1	Antiphospholipid AntibodiesIBA 07/2007
1	Prednisolone (Predate)FDA LinkGeneric 02/2007
1	LipidsIBA 01/2007
1	Denosumab FDA Link 06/2006

Therapy/Procedure

12	Therapeutics 06/2021 - 06/2002
5	Biological Therapy 01/2017 - 05/2006
1	Injections 03/2022
1	Replacement Arthroplasty 06/2006